ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

DAWN Day One Biopharmaceuticals Inc

17,25
-0,32 (-1,82%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Day One Biopharmaceuticals Inc DAWN NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,32 -1,82% 17,25 06:00:06
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
18,00 17,13 18,00 17,17 17,57
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
07.3.202422:19EDGAR2Form 8-K - Current report
29.2.202401:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:27EDGAR2Form 144 - Report of proposed sale of securities
21.2.202400:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:51EDGAR2Form 144 - Report of proposed sale of securities
17.1.202414:25EDGAR2Form 8-K - Current report
10.1.202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202401:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202414:30EDGAR2Form 8-K - Current report
04.1.202422:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
18.11.202300:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.11.202300:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.11.202313:07EDGAR2Form 8-K - Current report
17.11.202300:24EDGAR2Form 144 - Report of proposed sale of securities
15.11.202322:07EDGAR2Form 8-K - Current report
06.11.202322:48EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.11.202322:30EDGAR2Form 8-K - Current report
30.10.202315:54DJNDay One Biopharmaceuticals Shares Rally on FDA Priority..
30.10.202313:58DJNDay One Gets FDA Priority Review of Tovorafenib in Pediatric..
30.10.202313:12EDGAR2Form 8-K - Current report
20.10.202322:01EDGAR2Form SC 13D/A - General statement of acquisition of..
14.9.202323:28EDGAR2Form S-3ASR - Automatic shelf registration statement of..
11.9.202314:35EDGAR2Form 8-K - Current report
18.8.202300:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.8.202300:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.8.202314:06EDGAR2Form 8-K - Current report
07.8.202322:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.8.202322:30EDGAR2Form 8-K - Current report
06.7.202301:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.6.202313:00PRNUSKAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock